Drug information for NASALCROM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SPRAY, METERED; NASAL 5.2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Discontinued   CROMOLYN SODIUM Cromolyn Sodium BLACKSMITH BRANDS 20463
2004-07-21 Letter
2001-03-27 Review
2001-03-27 Letter

Drug Adverse Effects information for NASALCROM

Role code Indications Reaction # Reports
C BLOOD PRESSURE INCREASED BALANCE DISORDER 1
C BLOOD PRESSURE INCREASED DIZZINESS 1
C BLOOD PRESSURE INCREASED FATIGUE 1
C BLOOD PRESSURE INCREASED MUSCULAR WEAKNESS 1
C BLOOD PRESSURE INCREASED PLATELET COUNT DECREASED 1
C BLOOD PRESSURE INCREASED WHITE BLOOD CELL COUNT DECREASED 1
C CARDIAC FAILURE BALANCE DISORDER 1
C CARDIAC FAILURE DIZZINESS 1
C CARDIAC FAILURE FATIGUE 1
C CARDIAC FAILURE MUSCULAR WEAKNESS 1
C CARDIAC FAILURE PLATELET COUNT DECREASED 1
C CARDIAC FAILURE WHITE BLOOD CELL COUNT DECREASED 1
Ads by Google